Mindstrong is redefining behavioral healthcare by transforming how we diagnose and manage these disorders to improve outcomes.
Mindstrong was founded by some of the world’s leading authorities in neuroscience, oncology, and technology. It is based on their shared vision to redefine neuropsychiatric healthcare, transforming diagnosis and delivering precision therapy. Mindstrong builds on one of the founder’s patented biomarker platform developed over years of extensive clinical R&D.
Paul Dagum, MD PhD
Paul Dagum, M.D., Ph.D. is an entrepreneur, scientist and technologist with a track record of creating and launching product in three successful venture-backed companies. Dr. Dagum led NSF and NIH grants while at Stanford University, published over 70 peer-review articles and book chapters in computer science and medicine, and was awarded over 20 patents. Dr. Dagum received an MSc in theoretical physics, PhD in theoretical computer science both from the University of Toronto and an MD from Stanford University.
Tom Insel, MD
Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.
Rick Klausner, MD
Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.